157 related articles for article (PubMed ID: 1398516)
1. Solitary plasmacytoma of bone: clinical features, treatment and survival.
Ellis PA; Colls BM
Hematol Oncol; 1992; 10(3-4):207-11. PubMed ID: 1398516
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
3. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli MA; Russo D; Petrucci MT; Bucalossi A; Tura S
Ann Oncol; 1995 Sep; 6(7):687-91. PubMed ID: 8664190
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
6. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
[TBL] [Abstract][Full Text] [Related]
7. Solitary plasmacytoma of bone and soft tissues.
Tong D; Griffin TW; Laramore GE; Kurtz JM; Russell AH; Groudine MT; Herron T; Blasko JC; Tesh DW
Radiology; 1980 Apr; 135(1):195-8. PubMed ID: 7360960
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
[TBL] [Abstract][Full Text] [Related]
9. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of osteopenia and immunoparesis at presentation in patients with solitary myeloma of bone.
Jackson A; Scarffe JH
Eur J Cancer; 1990 Mar; 26(3):363-71. PubMed ID: 2141495
[TBL] [Abstract][Full Text] [Related]
11. Solitary bone plasmacytoma: Long-term clinical outcomes in a single center.
Gao S; Wang YT; Ma GY; Lu MQ; Chu B; Shi L; Fang LJ; Xiang QQ; Ding YH; Bao L
Curr Probl Cancer; 2024 Jun; 50():101095. PubMed ID: 38598973
[TBL] [Abstract][Full Text] [Related]
12. Upper humeral cortical thickness as an indicator of osteopenia: diagnostic significance in solitary myeloma of bone.
Jackson A; Scarffe JH
Skeletal Radiol; 1991; 20(5):363-7. PubMed ID: 1896877
[TBL] [Abstract][Full Text] [Related]
13. The role of radiation therapy in the treatment of solitary plasmacytomas.
Mayr NA; Wen BC; Hussey DH; Burns CP; Staples JJ; Doornbos JF; Vigliotti AP
Radiother Oncol; 1990 Apr; 17(4):293-303. PubMed ID: 2343147
[TBL] [Abstract][Full Text] [Related]
14. Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Fouquet G; Guidez S; Herbaux C; Van de Wyngaert Z; Bonnet S; Beauvais D; Demarquette H; Adib S; Hivert B; Wemeau M; Berthon C; Terriou L; Coiteux V; Macro M; Decaux O; Facon T; Huglo D; Leleu X
Clin Cancer Res; 2014 Jun; 20(12):3254-60. PubMed ID: 24714772
[TBL] [Abstract][Full Text] [Related]
15. Solitary plasmacytoma. II: Solitary plasmacytoma of bone.
Woodruff RK; Malpas JS; White FE
Cancer; 1979 Jun; 43(6):2344-7. PubMed ID: 455225
[TBL] [Abstract][Full Text] [Related]
16. Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.
Paiva B; Chandia M; Vidriales MB; Colado E; Caballero-Velázquez T; Escalante F; Garcia de Coca A; Montes MC; Garcia-Sanz R; Ocio EM; Mateos MV; San Miguel JF
Blood; 2014 Aug; 124(8):1300-3. PubMed ID: 24876564
[TBL] [Abstract][Full Text] [Related]
17. Solitary plasmacytoma.
Kayrouz T; Jose B; Chu AM; Scott RM
J Surg Oncol; 1983 Sep; 24(1):46-8. PubMed ID: 6887936
[TBL] [Abstract][Full Text] [Related]
18. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
19. Solitary plasmacytoma: experiences from Central Anatolia.
Coskun HS; Er O; Soyuer S; Altinbas M; Eser B; Karahacioglu E; Altuntas F
Ir J Med Sci; 2005; 174(1):33-6. PubMed ID: 15868887
[TBL] [Abstract][Full Text] [Related]
20. [Solitary bone plasmacytoma: about 3 cases and review of the literature].
Masmoudi K; Elleuch E; Akrout R; Mnejja MA; Feki A; Ezzeddine M; Baklouti S; Jemaâ B
Pan Afr Med J; 2016; 25():219. PubMed ID: 28292172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
